<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5A8AC1E5-EA82-42CC-9E91-F0294FBF578B"><gtr:id>5A8AC1E5-EA82-42CC-9E91-F0294FBF578B</gtr:id><gtr:name>Robert Koch Institute</gtr:name><gtr:address><gtr:line1>Robert Koch Institut</gtr:line1><gtr:line2>Nordufer 20</gtr:line2><gtr:line4>D-13353 Berlin-Wedding</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6BE14EEB-8C76-4661-A42D-5BBE8B8AC5ED"><gtr:id>6BE14EEB-8C76-4661-A42D-5BBE8B8AC5ED</gtr:id><gtr:name>Technical University Dresden</gtr:name><gtr:address><gtr:line1>TU Dresden</gtr:line1><gtr:postCode>D-01062</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/93B13D3A-863C-46E8-A4C7-1EE4759A7E9B"><gtr:id>93B13D3A-863C-46E8-A4C7-1EE4759A7E9B</gtr:id><gtr:name>Cleveland Clinic</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Sir William Dunn Sch of Pathology</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5A8AC1E5-EA82-42CC-9E91-F0294FBF578B"><gtr:id>5A8AC1E5-EA82-42CC-9E91-F0294FBF578B</gtr:id><gtr:name>Robert Koch Institute</gtr:name><gtr:address><gtr:line1>Robert Koch Institut</gtr:line1><gtr:line2>Nordufer 20</gtr:line2><gtr:line4>D-13353 Berlin-Wedding</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6BE14EEB-8C76-4661-A42D-5BBE8B8AC5ED"><gtr:id>6BE14EEB-8C76-4661-A42D-5BBE8B8AC5ED</gtr:id><gtr:name>Technical University Dresden</gtr:name><gtr:address><gtr:line1>TU Dresden</gtr:line1><gtr:postCode>D-01062</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/93B13D3A-863C-46E8-A4C7-1EE4759A7E9B"><gtr:id>93B13D3A-863C-46E8-A4C7-1EE4759A7E9B</gtr:id><gtr:name>Cleveland Clinic</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/EFD541EC-F53F-4F79-BFA5-8DCE70466421"><gtr:id>EFD541EC-F53F-4F79-BFA5-8DCE70466421</gtr:id><gtr:firstName>A</gtr:firstName><gtr:otherNames>Neil</gtr:otherNames><gtr:surname>Barclay</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0400808"><gtr:id>E263CE31-1B78-483F-823B-58AB04E6795F</gtr:id><gtr:title>Molecular analysis of the lymphocyte cell surface</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0400808</gtr:grantReference><gtr:abstractText>My first aim is to continue to ensure that our work is published as soon as possible in mainstream journals and in the form of reviews to meet a wider audience. The WWW is becoming very important in disseminating information and our WWW pages are regularly updated. I am keen on open access and I have contributed to the recent government enquiry on this subject. I have recently published an article in BMC Biochem with another to submitted later this month. The nature of our basic research is relatively technical and not disease oriented which limits interest to the media. However in the past press releases have led to TV and radio interest and I will continue to encourage these where appropriate. I will continue to take the opportunity to discuss the work and recently I was the focus for an article in the magazine Genome Technology (Feb 2003). We will continue to encourage visits from school members and one visit to a school is planned shortly (MHB). In addition two members of my group presented at the recent British Association for the Advancement of Science meeting in Manchester along with a former Post doc and this type of contact will be encouraged.</gtr:abstractText><gtr:technicalSummary>The immune system provides a system of cells that provide a highly controlled response of the optimal duration at the site of the pathogen and very rarely makes errors but in these circumstances they lead to autoimmune disease or cancer. It is through the interactions of these membrane molecules that the immune system is regulated and the characterisation of these interactions at a molecular level is central to understanding the immune system and improving therapies for autoimmune diseases, cancer and permitting transplantation. The programme continues the identification of these interactions and use of the resulting reagents to analyse their functions at a molecular level. The interactions are characterised quantitviely as this is essential in working out the relevant interactions in mediating fucntion. The major lines of research are; 
1. The systematic identification of interactions of T cell membrane proteins using existing methods and new protein microarray assays. 
2. The continuing detailed biochemical analysis of CD200/CD200R, CD47/SIRP and CD6/CD166 interactions that have been shown to regulate immune cells through cell cell contact 
3. Viral homologues of CD200 and CD47 will be characterised to understand their role in the virus and of the host protein. 
4. Proteins interacting with the cytoplasmic regions of the above receptors will be identified biochemically giving insight into the mode of transmission of signals. 
5. Model systems of immune reactions will be perturbed in vivo and in vitro using antibodies and recombinant proteins and changes in gene expression characterised to probe functional effects. 
6. Production of the extracellular regions of these proteins using cell lines with reduced glycosylation heterogeneity for X-ray crystallography using high throughput crystallisation methods at the MRC Oxford Protein Production Facility 
7. Further detailed functional analysis will be carried out in collaboration with academic and industrial partners and potential as therapeutics explored.</gtr:technicalSummary><gtr:fund><gtr:end>2010-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1200127</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cleveland Clinic</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Cellular &amp; Molecular Medicine</gtr:department><gtr:description>Interactions with extracellular matrix</gtr:description><gtr:id>BF91AC20-9FE2-47A1-B299-0293965D1B90</gtr:id><gtr:impact>18285447</gtr:impact><gtr:outcomeId>7E5266D6917-1</gtr:outcomeId><gtr:partnerContribution>The group are experts in extracelullar matrix and able to allow us to relate our biochemical data to their structure and functional data</gtr:partnerContribution><gtr:piContribution>We carried out BIAcore studies that complemented their studies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Technical University of Dresden</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Control of dendritic cell activity</gtr:description><gtr:id>01B27D93-6A6E-4928-AB01-342A77839F80</gtr:id><gtr:impact>16782032</gtr:impact><gtr:outcomeId>54A479CCE4D-1</gtr:outcomeId><gtr:partnerContribution>They did the majority of the functional experiments</gtr:partnerContribution><gtr:piContribution>We provided reagents and scientific input</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Sir William Dunn School of Pathology</gtr:department><gtr:description>X-ray crystallography of membrane proteins</gtr:description><gtr:id>8F9ADE5A-B600-4E0B-8D5C-018F4A559726</gtr:id><gtr:impact>One structure has been solved and another is on the way (no published). The collaboration allows direct access to X-ray crystallography with one member of my group working at alls tages</gtr:impact><gtr:outcomeId>VJtaCLtZPma-1</gtr:outcomeId><gtr:partnerContribution>This new collaboration has now been set up with Susan Lea's group in Pathology. One structure has been solved and another is on the way (not published)</gtr:partnerContribution><gtr:piContribution>A new collaboration has now been set up with Susan Lea's group in Pathology. One structure has been solved and another is on the way (no published)</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Wellcome Trust Centre for Human Genetics</gtr:department><gtr:description>X-ray crystallography of membrane proteins</gtr:description><gtr:id>BBFFE418-7F9D-4217-8692-551DA3162BF8</gtr:id><gtr:impact>19628875 18657508 17369261</gtr:impact><gtr:outcomeId>13FB9868850-1</gtr:outcomeId><gtr:partnerContribution>We had a joint project that led to high profiile publications</gtr:partnerContribution><gtr:piContribution>We made all the proteins, set up crystallisation trials using faciliteis at Wellcome Trust Centre. They solved the crystal structures and helped in their analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC National Institute for Medical Research (NIMR)</gtr:department><gtr:description>Structure of CD5</gtr:description><gtr:id>E29C7727-BF5F-472F-904C-0A37FC36C087</gtr:id><gtr:impact>18339402</gtr:impact><gtr:outcomeId>B72581BB8D9-2</gtr:outcomeId><gtr:partnerContribution>This collaborator solved the structure of protein involved in T cell recognition. This was technically very difficult and the successful approach was reached after many attempts and more than 10 years.Our collaborator solved the NMR structure of CD5 that we study. This was technically very difficult and many appraches were attempted over more than 10 years</gtr:partnerContribution><gtr:piContribution>We made recombinant proteins, tested mutants made by NIMR and advised on significance</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Kennedy Institute of Rheumatology</gtr:department><gtr:description>Role of CD200/CD200R in viral infection</gtr:description><gtr:id>8A9B75DC-EFD0-40E3-8379-C40A3049D608</gtr:id><gtr:impact>18660812</gtr:impact><gtr:outcomeId>A663E4443E8-1</gtr:outcomeId><gtr:partnerContribution>It allowed expansion of our studies on CD200/CD200R to be expanded into the area of viral infection</gtr:partnerContribution><gtr:piContribution>We provided reagents and data about biochemical analysis vital for interpretation</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Robert Koch-Institut RKI</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Analysis of viral homologues</gtr:description><gtr:id>1322ACD5-51CA-4F15-9666-0DA239525567</gtr:id><gtr:impact>Publication 19570854. Continuing to follow up results under curent programme grant</gtr:impact><gtr:outcomeId>6C06F30D636-1</gtr:outcomeId><gtr:partnerContribution>On going collaboration that should lead to publishable results</gtr:partnerContribution><gtr:piContribution>We analysed the reaction between a viral protein and the host receptor. Viral work carried out by collaborator.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC National Institute for Medical Research (NIMR)</gtr:department><gtr:description>Structure of CD5</gtr:description><gtr:id>8B39ADF9-53E6-476A-AEFE-34CDDE9ACA83</gtr:id><gtr:impact>18339402</gtr:impact><gtr:outcomeId>B72581BB8D9-1</gtr:outcomeId><gtr:partnerContribution>This collaborator solved the structure of protein involved in T cell recognition. This was technically very difficult and the successful approach was reached after many attempts and more than 10 years.Our collaborator solved the NMR structure of CD5 that we study. This was technically very difficult and many appraches were attempted over more than 10 years</gtr:partnerContribution><gtr:piContribution>We made recombinant proteins, tested mutants made by NIMR and advised on significance</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Talk to West Oxford Academy by group member</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>6575D794-2953-4653-9BB9-82C376A8EA3C</gtr:id><gtr:impact>Talk and discussion to local group in Oxford

Considerable interest and postive feedback of interest</gtr:impact><gtr:outcomeId>4FF62368AD4</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1800000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Research Grant</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>970E522F-6119-43B4-A79B-8D0C7E861989</gtr:id><gtr:outcomeId>1DCC216E2BF0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>190000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Research Grant</gtr:description><gtr:end>2010-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>4848AC88-47EB-4419-8FC5-5150639565C9</gtr:id><gtr:outcomeId>6C8CB55B4C70</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>210000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant (The structural basis of the binding specificity of the family of SIRP paired receptors)</gtr:description><gtr:end>2011-04-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>0470E257-9443-4BFC-AB59-C247CE43AD58</gtr:id><gtr:outcomeId>FC658BDCF870</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Monoclonal antibody</gtr:description><gtr:id>FDF2BE9A-4306-49F2-B36E-4CEFC9ED6F72</gtr:id><gtr:impact>gives new insight into family of receptors</gtr:impact><gtr:outcomeId>2B3F2E8284A</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Monoclonal antibody</gtr:title><gtr:type>Antibody</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We developed new ways to detect the weak protein interactions that are common for cell surface proteins but difficult to detect.</gtr:description><gtr:id>FD4801A6-45A3-40FA-873A-270520B39F20</gtr:id><gtr:impact>We identified one particuarly interesting interaction and we and others are using the technique.</gtr:impact><gtr:outcomeId>F45210166BE</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Multivalent reagents to detect weak protein interactions</gtr:title><gtr:type>Data analysis technique</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Monoclonal antibodies have been made that recongise membrane proteins. They are vital for our research but we continue to make them widely available to the scientific community by direct distribution and through commercialisation.</gtr:description><gtr:id>EBA80EAA-3F6D-4944-B33B-98359171934D</gtr:id><gtr:impact>They allow proteins to be recognised. Equivalent reagents have not been produced by others</gtr:impact><gtr:outcomeId>3E0C409E1FF</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Monoclonal antibodies</gtr:title><gtr:type>Antibody</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>BB70271B-C593-4A99-87D3-08EB9DE4D661</gtr:id><gtr:title>Interleukin-2 signalling is modulated by a labile disulfide bond in the CD132 chain of its receptor.</gtr:title><gtr:parentPublicationTitle>Open biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d61a8e019181cfb919b7ee6f4053188"><gtr:id>4d61a8e019181cfb919b7ee6f4053188</gtr:id><gtr:otherNames>Metcalfe C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2046-2441</gtr:issn><gtr:outcomeId>pm_14072_22_22645657</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>624A002E-4949-4CB2-B23A-66DDD9E538EA</gtr:id><gtr:title>Structures of CD6 and Its Ligand CD166 Give Insight into Their Interaction.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a3b7b79f5c0c5682d740644d41c5194"><gtr:id>1a3b7b79f5c0c5682d740644d41c5194</gtr:id><gtr:otherNames>Chappell PE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>5675e7e87570b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C27B0D9F-1E9A-4775-8EC3-066379832733</gtr:id><gtr:title>Signal regulatory protein alpha (SIRPalpha)/CD47 interaction and function.</gtr:title><gtr:parentPublicationTitle>Current opinion in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db46017da74e2d4b23371233a2fe3d6e"><gtr:id>db46017da74e2d4b23371233a2fe3d6e</gtr:id><gtr:otherNames>Barclay AN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0952-7915</gtr:issn><gtr:outcomeId>43008AB4A73</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED1380BB-1DE9-4700-A51C-8F50D634926F</gtr:id><gtr:title>A pipeline for the production of antibody fragments for structural studies using transient expression in HEK 293T cells.</gtr:title><gtr:parentPublicationTitle>Protein expression and purification</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5083c27c32694a5a97d0d79ec526d5b9"><gtr:id>5083c27c32694a5a97d0d79ec526d5b9</gtr:id><gtr:otherNames>Nettleship JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1046-5928</gtr:issn><gtr:outcomeId>AD2361EE016</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84EE38B5-45D5-4A74-87F6-D6566EB67AA0</gtr:id><gtr:title>Heterogeneity in the CD200R paired receptor family.</gtr:title><gtr:parentPublicationTitle>Immunogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/254f024c16d865180d3aedd11b23fa3e"><gtr:id>254f024c16d865180d3aedd11b23fa3e</gtr:id><gtr:otherNames>Akkaya M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0093-7711</gtr:issn><gtr:outcomeId>pBUKeTwLop4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>418A7BDE-B41D-4E7D-B750-A7FFB5576F9C</gtr:id><gtr:title>CD6 as a Cell Surface Receptor and As a Target for Regulating Immune Responses.</gtr:title><gtr:parentPublicationTitle>Current drug targets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f813b753cdd1e70c26f40ef787b53d58"><gtr:id>f813b753cdd1e70c26f40ef787b53d58</gtr:id><gtr:otherNames>Brown MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1389-4501</gtr:issn><gtr:outcomeId>585d57a70473a5.88218119</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD01B94D-0C30-481D-B035-61BC58A7CD33</gtr:id><gtr:title>Extracellular matrix retention of thrombospondin 1 is controlled by its conserved C-terminal region.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0cbb38ad0f9c3ccaf661bd38a8517fb0"><gtr:id>0cbb38ad0f9c3ccaf661bd38a8517fb0</gtr:id><gtr:otherNames>Adams JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>03F216E7BF6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0246D905-DF14-4C82-9784-4FC0ADE0855E</gtr:id><gtr:title>The counterbalance theory for evolution and function of paired receptors.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db46017da74e2d4b23371233a2fe3d6e"><gtr:id>db46017da74e2d4b23371233a2fe3d6e</gtr:id><gtr:otherNames>Barclay AN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>DCE66CCD73D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79922270-B239-4FDE-AFD0-77D0455E78D7</gtr:id><gtr:title>Identification of leucocyte surface protein interactions by high-throughput screening with multivalent reagents.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92b50da26a80fd7153eb54402d918dff"><gtr:id>92b50da26a80fd7153eb54402d918dff</gtr:id><gtr:otherNames>Jiang L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>793DDFBED9A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B0E331B-F1FC-4CD9-9DE5-829FB7AB2E8C</gtr:id><gtr:title>CD6 regulates T-cell responses through activation-dependent recruitment of the positive regulator SLP-76.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e4196af27f37d2a2cc3ea94a34057ac"><gtr:id>0e4196af27f37d2a2cc3ea94a34057ac</gtr:id><gtr:otherNames>Hassan NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>336A449DE3E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74688C29-5586-4937-BB53-C590320E3EF8</gtr:id><gtr:title>A ligand for CD5 is CD5.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f813b753cdd1e70c26f40ef787b53d58"><gtr:id>f813b753cdd1e70c26f40ef787b53d58</gtr:id><gtr:otherNames>Brown MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>WK76N4VMu7r</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14567E58-FFE0-42DE-9A77-F99889E95EF4</gtr:id><gtr:title>The structure of the macrophage signal regulatory protein alpha (SIRPalpha) inhibitory receptor reveals a binding face reminiscent of that used by T cell receptors.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49b18b8a2d6abc4fab7a4805d65e8c30"><gtr:id>49b18b8a2d6abc4fab7a4805d65e8c30</gtr:id><gtr:otherNames>Hatherley D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>20DED6A4BBB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73A3E28F-3A32-4323-962E-A124091D6C4E</gtr:id><gtr:title>Downstream of tyrosine kinase 1 and 2 play opposing roles in CD200 receptor signaling.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4f48cee2e46348c1d2864bad83c9ac2"><gtr:id>c4f48cee2e46348c1d2864bad83c9ac2</gtr:id><gtr:otherNames>Mihrshahi R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>3594121B_93594121B_9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20BFF643-8D33-4DE7-8086-9D4418BB58BA</gtr:id><gtr:title>Inhibition and activation by CD244 depends on CD2 and phospholipase C-gamma1.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26156859122c590f92a50cca65e71198"><gtr:id>26156859122c590f92a50cca65e71198</gtr:id><gtr:otherNames>Clarkson NG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>F60757B10EE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76EDED38-428D-4820-B2C8-24738DDAD13B</gtr:id><gtr:title>Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4f48cee2e46348c1d2864bad83c9ac2"><gtr:id>c4f48cee2e46348c1d2864bad83c9ac2</gtr:id><gtr:otherNames>Mihrshahi R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>21B06744BB6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67C02658-27A0-4A15-A796-A58ECB68B845</gtr:id><gtr:title>Direct and indirect interactions of the cytoplasmic region of CD244 (2B4) in mice and humans with FYN kinase.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26156859122c590f92a50cca65e71198"><gtr:id>26156859122c590f92a50cca65e71198</gtr:id><gtr:otherNames>Clarkson NG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>8E2D08CB3E6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51D2B8CE-855E-4650-90CC-A96C9C41CE21</gtr:id><gtr:title>Fine specificity and molecular competition in SLAM family receptor signalling.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd84fa3ce589572e309b82fa902b1b37"><gtr:id>fd84fa3ce589572e309b82fa902b1b37</gtr:id><gtr:otherNames>Wilson TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_540e13ce13c270fff</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5BCA21EE-6B9A-4EBF-922E-D6F482E20484</gtr:id><gtr:title>A polymorphism in a phosphotyrosine signalling motif of CD229 (Ly9, SLAMF3) alters SH2 domain binding and T-cell activation.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b126a222e1f4b80e36f49cb4f537b609"><gtr:id>b126a222e1f4b80e36f49cb4f537b609</gtr:id><gtr:otherNames>Margraf S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>585d57f5bd62f8.09542481</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37C8AB9C-8CD2-47F5-A335-2CC7AEBD0F2C</gtr:id><gtr:title>Inhibition of macrophage activation by the myxoma virus M141 protein (vCD200).</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/917fedf7d4ac4a5d4fbb9db6070723d7"><gtr:id>917fedf7d4ac4a5d4fbb9db6070723d7</gtr:id><gtr:otherNames>Zhang L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>C2C3F0F8108</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48BA888D-0961-4040-8F83-9A94DA2310A5</gtr:id><gtr:title>Labile disulfide bonds are common at the leucocyte cell surface.</gtr:title><gtr:parentPublicationTitle>Open biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d61a8e019181cfb919b7ee6f4053188"><gtr:id>4d61a8e019181cfb919b7ee6f4053188</gtr:id><gtr:otherNames>Metcalfe C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>2046-2441</gtr:issn><gtr:outcomeId>doi_55f9839838da53e0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>53412D19-07BE-4A43-BBFB-A72C2BA2A53E</gtr:id><gtr:title>Three-dimensional solution structure and conformational plasticity of the N-terminal scavenger receptor cysteine-rich domain of human CD5.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb650e879e99928c8730519c96821faa"><gtr:id>bb650e879e99928c8730519c96821faa</gtr:id><gtr:otherNames>Garza-Garcia A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>57CF998A74C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>676E00F4-261E-404F-9494-D813877671C0</gtr:id><gtr:title>Immune inhibitory ligand CD200 induction by TLRs and NLRs limits macrophage activation to protect the host from meningococcal septicemia.</gtr:title><gtr:parentPublicationTitle>Cell host &amp; microbe</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f803f62cc8af558276c3a46333dd2697"><gtr:id>f803f62cc8af558276c3a46333dd2697</gtr:id><gtr:otherNames>Mukhopadhyay S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1931-3128</gtr:issn><gtr:outcomeId>aQM77sAzLad</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54EC1428-C049-4288-B9C5-3780722F1221</gtr:id><gtr:title>Human 6-sulfo LacNAc-expressing dendritic cells are principal producers of early interleukin-12 and are controlled by erythrocytes.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d1c3b6a58745761c2c72076a2db634f"><gtr:id>0d1c3b6a58745761c2c72076a2db634f</gtr:id><gtr:otherNames>Sch?kel K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>F920A1C33D5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F09D85D6-E6A5-45E3-9DE2-7A5E2EBC5A2C</gtr:id><gtr:title>Secreted and transmembrane 1A is a novel co-stimulatory ligand.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ee12a2614ed8a1358b7add17f976e24"><gtr:id>0ee12a2614ed8a1358b7add17f976e24</gtr:id><gtr:otherNames>Howie D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14072_22_24039998</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C71D28E9-2742-481E-9F36-DB0443AEC369</gtr:id><gtr:title>CD6 as a Cell Surface Receptor and As a Target for Regulating Immune Responses</gtr:title><gtr:parentPublicationTitle>Current Drug Targets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0005bd94b71a4c6da65a6c02291456fc"><gtr:id>0005bd94b71a4c6da65a6c02291456fc</gtr:id><gtr:otherNames>H. Brown M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>585d65a2d153c9.32576061</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>487108C8-5E84-4A8E-829E-D50A61227780</gtr:id><gtr:title>New assay to detect low-affinity interactions and characterization of leukocyte receptors for collagen including leukocyte-associated Ig-like receptor-1 (LAIR-1).</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92b50da26a80fd7153eb54402d918dff"><gtr:id>92b50da26a80fd7153eb54402d918dff</gtr:id><gtr:otherNames>Jiang L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>2F5A590450E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C69A854C-96FE-498F-80D2-9CC618150CC1</gtr:id><gtr:title>A critical function for CD200 in lung immune homeostasis and the severity of influenza infection.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e89c7491a7c08182477b643557a4377"><gtr:id>1e89c7491a7c08182477b643557a4377</gtr:id><gtr:otherNames>Snelgrove RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>A395B092DB5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B75D074-AB2C-4EA6-8740-92728B5852A3</gtr:id><gtr:title>The SIRP family of receptors and immune regulation.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db46017da74e2d4b23371233a2fe3d6e"><gtr:id>db46017da74e2d4b23371233a2fe3d6e</gtr:id><gtr:otherNames>Barclay AN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>59DDF4403F5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A224F70-C286-4D04-8789-61F6774B69EE</gtr:id><gtr:title>Structure of signal-regulatory protein alpha: a link to antigen receptor evolution.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49b18b8a2d6abc4fab7a4805d65e8c30"><gtr:id>49b18b8a2d6abc4fab7a4805d65e8c30</gtr:id><gtr:otherNames>Hatherley D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>7ADAD51945B</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0400808</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>